Aesculap Implant Systems won FDA regulatory approval to market the firm’s S4 Cervical System. The device is intended for fusions of cervical and thoracic spine (C1 to T3) and occipito-cervico-thoracic junction (occiput to T3).
From the product page:
The S4 Cervical System offers maximum versatility through its wide range of implant selection and instrumentation to meet the special needs of the cervical and thoracic spine.
By combining the exceptionally small, yet stable design of the screw construct with simple instrumentation, the S4 Cervical System is a remarkably safe system for posterior column fixation. Small implant volume, overall biomechanical strength and easy access instruments help to achieve a fast and efficient surgical procedure with optimal patient outcome.